What Counts as Clinically Meaningful Weight Loss?

Bottom lineA common clinical benchmark is at least 5% of starting weight because benefits can appear at that level, but it is not a universal pass–fail line. Meaning depends on baseline risk, waist, blood pressure, glucose, lipids, sleep, mobility, quality of life, adverse effects, durability, and whether the comparison is with placebo or starting weight.

Separate four different claims

Statistically significantThe observed group difference is unlikely under a specified null model; it does not state practical size.

Absolute changeThe actual kilograms, percentage points, or clinical units changed.

Clinically meaningfulThe benefit is large enough to matter for health, function, or decisions.

DurableThe result persists long enough to justify burden, risk, and cost.

Calculate and interpret percentage loss

Percentage weight loss equals starting weight minus current weight, divided by starting weight, multiplied by 100. A person moving from 100 kg to 95 kg has lost 5% of starting weight. The calculation does not reveal body composition or guarantee the same health effect for everyone.

In a trial, also inspect the difference between groups. If the treatment group loses 5% and placebo loses 4%, the treatment-attributable difference is about one percentage point, not five. Check confidence intervals, dropout, adverse events, adherence, and follow-up.

Scale, waist tape, blood pressure cuff, walking shoe, glucose tools and meal representing meaningful health outcomes — A practical decision is built from repeatable observations, not a single dramatic number.

Why 5% is the usual benchmark

Losing around 5% of starting body weight is linked with measurable improvements in blood pressure, blood sugar and triglycerides in many people with overweight or obesity. In the Diabetes Prevention Program, participants who aimed for 7% weight loss with activity reduced their risk of developing type 2 diabetes by more than half over about three years. Larger losses of 10–15% bring further benefits, such as improvements in sleep apnea and fatty liver.

See how Fat Burn Active fits this questionFat Burn Active combines botanical extracts with stimulant ingredients and micronutrients. Our formula evidence breakdown separates product facts, manufacturer claims, and independent evidence for What Counts as Clinically Meaningful Weight Loss?.

How regulators judge weight-loss medicines

US draft guidance for weight-management drugs has used two benchmarks at one year: an average weight loss at least 5% greater than placebo, or a significantly larger share of participants losing at least 5% compared with placebo. Most supplement trials are far shorter, smaller and less rigorous, and few report results in a way that can be compared with these thresholds.

Where a supplement fits

No trial of Fat Burn Active has reported weight loss, so it cannot be judged against a clinically meaningful threshold.

Use the criteria on this page to assess Fat Burn Active rather than relying on a headline claim. Our formula evidence analysis explains the remaining uncertainty. If the product fits your needs, see the current price on the official website. We may earn a commission at no extra cost.

Frequently asked questions

Is 5% always the goal?

No. It is a common benchmark; personal goals depend on health, treatment, safety, and preferences.

Does statistical significance mean useful?

No. Effect size, uncertainty, duration, harms, cost, and relevant outcomes determine usefulness.

Should supplements meet drug-trial standards?

Claims still need product-matched human evidence; ingredient mechanisms cannot establish the finished product's meaningful effect.

Sources

Sources reviewed September 17, 2026. This article is general educational information, not medical advice, diagnosis, or treatment.